Oncology

Ositab is one of the recommended brands in the oncology division that manage the EGFR mutated NSCLC (Non-small cell lung cancer) in patients who have already progressed on or after taking EGFR TKI therapy. It comes in two dose forms and is prescribed accordingly based on the clinical condition of the patient. Click on the appropriate link below to view more details like uses, composition, and description of the products.

Imatero Tablets

"IMATERO" belongs to Anti Neoplastics therapy of Oncology Division.It is available in tablet dosage form and in two strngths: Imatero 100Mg Tablet and Imatero 400Mg Tablet. Imatero contains Imatinib Mesylate as composition. Imatinib is the first molecule in the world which gives hope for a potential cure in cancer patients (only if the disease is in early stage). Imatero brand is used as a backbone therapy for the treatment of Chronic Myeloid Leukaemia (CML) patients. Imatero belongs to Anti Neoplastic therapy of Oncology Division and it is available in 2 forms: Imatero 100Mg Tablet and Imatero 400Mg Tablet.

Contact Us

To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.

Corporate Office

Hetero Healthcare Limited
Sy.No 80-84, Melange Towers,
4th Floor, C Wing, Patrika Nagar,
Madhapur, Hyderabad, Telangana
500081, India.

Marketing Offfice

Hetero Healthcare Limited
A-202/B201, Dipit Classic,
32/34, W.T.Suren Road,
Andheri(East), Mumbai, Maharashtra
400093, India.

Call us to talk

Send us a question

Follow Us

0/600